Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2022 Sep:120:106891.
doi: 10.1016/j.cct.2022.106891. Epub 2022 Aug 21.

Successful recruitment of monolingual Spanish speaking Latinos to university phase II and III outpatient COVID-19 clinical treatment trials in Northern California

Vivian Levy  1 , Ruth Yanes Bengoa  2 , Priscilla Padilla Romero  3 , Jenna Bollyky  4 , Upinder Singh  5
Affiliations
Clinical Trial

Successful recruitment of monolingual Spanish speaking Latinos to university phase II and III outpatient COVID-19 clinical treatment trials in Northern California

Vivian Levy et al. Contemp Clin Trials. 2022 Sep.

Abstract

Through a public County/University partnership, we employed a Spanish/English bilingual research coordinator to increase awareness of newly available treatments with FDA Emergency Use Authorization and clinical trial opportunities for Latino outpatients with mild to moderate COVID-19. Out of the 550 San Mateo County outpatients with COVID-19 referred to Stanford University between July 2020 and April 2022, 9.5% elected to receive monoclonal antibody EUA treatment. COVID-19 treatment trial enrollment of County patients, 5% of those recruited, was commensurate with non-County populations enrollment. Recruitment models such as ours have the potential to increase US Latino populations' recruitment in outpatient COVID-19 treatment trials and contribute to decreasing COVID-19 health disparities.

Keywords: COVID-19; Latino; Recruitment.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Kaiser Family Foundation. Racial Diversity within COVID-19 Vaccine Clinical Trials: Key Questions and Answers. Accessed May 29, 2022. Available at: https://www.kff.org/racial-equity-and-health-policy/issue-brief/racial-d....
    1. US Food and Drug Administration. Clinical Trial Diversity. Accessed May 27, 2022. Available at: https://www.fda.gov/consumers/minority-health-and-health-equity/clinical....
    1. US Department of Health and Human Services . US Dept of Health and Human Services; Enhancing the Diversity of Clinical Trial Populations- Eligibility Criteria, Enrollment Practices and Trial Design Guidance for Industry: November 2020. Food and Drug Administration, Center for Drug Evaluation and Research, Centers for Biologics Evaluation and Research.
    1. Oliveira J., e Silva L., Gerberi D., Cummins N., Shah A., Bellolio F. Representativeness of racial and ethnic groups in COVID-19 outpatient trials in the United States. Mayo Clin. Proc. 2022;97(1):184–186. - PMC - PubMed
    1. Jaklevic M. Researchers strive to recruit hard-hit minorities into COVID-19 vaccine trials. JAMA. 2020;324(9):826–828. - PubMed

Publication types

Substances